ICISConnect

Browse by Tags

Sign of things to come?

The big news today is Daiichi Sankyo's acquisition of a controlling stake in Ranbaxy , India's largest pharmaceutical company, for $4.6bn. Analysts have been quick to predict many more such deals which will see international pharma majors entering the generic space. Indian generic players have...

Posted to ICIS Blogs (Weblog) by Anonymous on 06-12-2008
Struggling with Reach

Are Indian chemical companies ready for Reach? Apparently not, says this report in today's Mint. The problem appears to be not only lack of awareness about the EU programme for registration, evaluation and authorisation of chemicals (Reach) but also a shortage of labs certified for good laboratory...

Posted to ICIS Blogs (Weblog) by Anonymous on 05-27-2008
Testing times for CRAMS

Business is booming in India’s custom research and manufacturing services (CRAMS) industry thanks to the country's strong process chemistry skills, low operational costs and the availability of a skilled workforce. Frost & Sullivan values the Indian CRAMS market at $890m, and expects it to expand...

Posted to ICIS Blogs (Weblog) by Anonymous on 02-11-2008

Page 1 of 1 (3 items)